@kmartfit's enclomiphene dosing claims need more context
Quick answer
Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis. The creator presents a specific dosing protocol (25mg three times weekly) drawn from personal use rather than published guidelines or physician direction. Concurrent use of enclomiphene with exogenous testosterone remains understudied in peer-reviewed literature, and outcomes including testicular atrophy prevention have not been definitively established at this dose or schedule.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The creator says they personally take "25 milligrams three times a week" of what they call "end chlamorrhine" (enclomiphene) while on TRT, and that this dose "completely keeps my bulge from shrinking" and helps maintain fertility. That's three specific claims packed into about 15 seconds: a dose, a testicular volume effect, and a fertility benefit. Let's take them apart.
To be clear about terminology: enclomiphene is the trans-isomer of clomiphene citrate. It works as a selective estrogen receptor modulator (SERM) that blocks hypothalamic estrogen feedback, triggering the release of LH and FSH. Those gonadotropins then signal the testes to produce testosterone and continue sperm production, even when exogenous testosterone would otherwise suppress that axis. The mechanism is real and reasonably well understood.
Does the science back this up?
Partially, but the confidence in that specific dosing protocol is much weaker than the creator implies. The fertility-preservation angle has some legitimate backing. The testicular shrinkage claim has less direct evidence specifically for enclomiphene on TRT.
Kim et al. (2013, Fertility and Sterility) showed clomiphene citrate restored spermatogenesis in hypogonadal men, and since enclomiphene is the active isomer, there's biological plausibility for the fertility argument. Wiehle et al. (2013, The Aging Male) looked at enclomiphene specifically and found it raised LH, FSH, and testosterone in hypogonadal men. But these studies were in men not already on exogenous testosterone. Using enclomiphene concurrently with TRT is a different scenario, one that has far less clinical trial data behind it.
The 25mg three-times-weekly dose is not from a published guideline. It appears to be a community-derived protocol circulating in TRT forums and optimization circles. That doesn't automatically make it wrong, but it means the creator is presenting personal experimentation as if it were established practice.
What did they get wrong (or right)?
The creator gets the general concept right: exogenous testosterone suppresses the HPG axis, reducing LH and FSH, which causes testicular atrophy and impairs spermatogenesis. Using a SERM to partially rescue gonadotropin signaling while on TRT is a real clinical strategy. Some physicians do prescribe this combination, particularly for men who want to preserve fertility options.
What they get wrong is the certainty. Saying enclomiphene "completely" prevents testicular shrinkage is not supported by evidence. Testicular volume on TRT depends on multiple factors, including baseline size, duration of use, and individual HPG sensitivity. There is no published study demonstrating complete prevention of testicular atrophy with this combination at this dose.
The dose itself is a problem to broadcast. Presenting a personal dose as a general answer to "what is my dosage" implies it applies broadly. Enclomiphene dosing in clinical studies has ranged from 12.5mg to 25mg daily, not three times weekly, and those studies were not in men on concurrent TRT. The pharmacokinetics in that combined context have not been well characterized in peer-reviewed literature.
What should you actually know?
If you're on TRT and concerned about fertility or testicular atrophy, you have real options, but they require an actual clinical conversation, not a TikTok protocol. Human chorionic gonadotropin (hCG) has a longer track record for this purpose and is the more commonly studied option. Enclomiphene as an adjunct to TRT is an area of genuine clinical interest but is not yet standard of care.
A 2020 review by Patel et al. (Therapeutic Advances in Urology) noted that while SERMs show promise for male hypogonadism, concurrent use with exogenous androgens remains under-studied. Any man considering this combination should have FSH, LH, and semen analysis monitored, not just testosterone levels.
The broader issue here is that this video is structured as a dosing recommendation from a non-clinician, delivered with total confidence, to an audience that may take it as medical guidance. That's a legitimate concern regardless of whether the underlying concept has any merit.
Is enclomiphene even legally prescribed for this use?
That depends heavily on where you are. Enclomiphene is not FDA-approved as a standalone drug in the United States. The branded version (Androxal) completed Phase III trials but was not approved. Enclomiphene is available through compounding pharmacies in the US, prescribed off-label by some men's health and urology clinicians. It is not an over-the-counter supplement. Anyone sourcing it outside a licensed prescriber is operating in legally and medically murky territory, and the creator makes no mention of this context at all.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @kmartfit's enclomiphene dosing claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@kmartfit's enclomiphene dosing claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis.
FormBlends verdict
Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis. The creator presents a specific dosing protocol (25mg three times weekly) drawn from personal use rather than published guidelines or physician direction. Concurrent use of enclomiphene with exogenous testosterone remains understudied in peer-reviewed literature, and outcomes including testicular atrophy prevention have not been definitively established at this dose or schedule.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis. The creator presents a specific dosing protocol (25mg three times weekly) drawn from personal use rather than published guidelines or physician direction. Concurrent use of enclomiphene with exogenous testosterone remains understudied in peer-reviewed literature, and outcomes including testicular atrophy prevention have not been definitively established at this dose or schedule.
- Enclomiphene is not FDA-approved in the US; it is available only through compounding pharmacies via off-label prescriptions, a fact the video omits entirely.
- Wiehle et al. (2013) studied enclomiphene at 12.5-25mg daily in non-TRT users, not at the three-times-weekly schedule the creator promotes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Enclomiphene is not FDA-approved in the US; it is available only through compounding pharmacies via off-label prescriptions, a fact the video omits entirely.
- Wiehle et al. (2013) studied enclomiphene at 12.5-25mg daily in non-TRT users, not at the three-times-weekly schedule the creator promotes.
- hCG (human chorionic gonadotropin) has more published evidence for preserving testicular function and fertility during TRT than enclomiphene does in this context.
- A 2020 review by Patel et al. (Therapeutic Advances in Urology) flagged SERM use concurrent with exogenous androgens as under-studied, meaning safety and efficacy data are genuinely incomplete.
- Testicular atrophy on TRT is multifactorial; no compound has been shown to completely prevent it, making the creator's 'completely' claim an overstatement not backed by evidence.
- Anyone considering enclomiphene as a TRT adjunct should have LH, FSH, and semen analysis monitored, not just testosterone, to assess whether gonadotropin signaling is actually being preserved.
- Self-reported personal dosing protocols on social media, however well-intentioned, are not substitutes for individualized clinical assessment, especially for off-label drug combinations.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
19.1K views on this video
What’s My Dosage of Enclomiphene While on Testosterone Replacement Therapy? If you’re on TRT and wondering how to maintain fertility and avoid testicular shrinkage, here’s what I do: I take 25 mg of
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.